172 related articles for article (PubMed ID: 34462275)
1. SNAI2-Mediated Repression of
Wang L; Hensch NR; Bondra K; Sreenivas P; Zhao XR; Chen J; Moreno Campos R; Baxi K; Vaseva AV; Sunkel BD; Gryder BE; Pomella S; Stanton BZ; Zheng S; Chen EY; Rota R; Khan J; Houghton PJ; Ignatius MS
Cancer Res; 2021 Nov; 81(21):5451-5463. PubMed ID: 34462275
[TBL] [Abstract][Full Text] [Related]
2. Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.
Pomella S; Sreenivas P; Gryder BE; Wang L; Milewski D; Cassandri M; Baxi K; Hensch NR; Carcarino E; Song Y; Chou HC; Yohe ME; Stanton BZ; Amadio B; Caruana I; De Stefanis C; De Vito R; Locatelli F; Chen Y; Chen EY; Houghton P; Khan J; Rota R; Ignatius MS
Nat Commun; 2021 Jan; 12(1):192. PubMed ID: 33420019
[TBL] [Abstract][Full Text] [Related]
3. Sensitization to Ionizing Radiation by MEK Inhibition Is Dependent on SNAI2 in Fusion-Negative Rhabdomyosarcoma.
Hensch NR; Bondra K; Wang L; Sreenivas P; Zhao XR; Modi P; Vaseva AV; Houghton PJ; Ignatius MS
Mol Cancer Ther; 2023 Jan; 22(1):123-134. PubMed ID: 36162055
[TBL] [Abstract][Full Text] [Related]
4. A SNAI2/CTCF Interaction is Required for
Sreenivas P; Wang L; Wang M; Challa A; Modi P; Hensch NR; Gryder B; Chou HC; Zhao XR; Sunkel B; Moreno-Campos R; Khan J; Stanton BZ; Ignatius MS
Mol Cell Biol; 2023; 43(11):547-565. PubMed ID: 37882064
[TBL] [Abstract][Full Text] [Related]
5. The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3β/β-CATENIN signal pathway.
Tian X; Tao F; Zhang B; Dong JT; Zhang Z
IUBMB Life; 2018 Mar; 70(3):224-236. PubMed ID: 29389061
[TBL] [Abstract][Full Text] [Related]
6. Alcohol-mediated calcium signals dysregulate pro-survival Snai2/PUMA/Bcl2 networks to promote p53-mediated apoptosis in avian neural crest progenitors.
Flentke GR; Baulch JW; Berres ME; Garic A; Smith SM
Birth Defects Res; 2019 Jul; 111(12):686-699. PubMed ID: 31021056
[TBL] [Abstract][Full Text] [Related]
7. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
8. Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers.
Boufraqech M; Zhang L; Nilubol N; Sadowski SM; Kotian S; Quezado M; Kebebew E
Clin Cancer Res; 2016 Sep; 22(17):4491-504. PubMed ID: 27029493
[TBL] [Abstract][Full Text] [Related]
9. Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activity.
Orr WS; Denbo JW; Saab KR; Ng CY; Wu J; Li K; Garner JM; Morton CL; Du Z; Pfeffer LM; Davidoff AM
PLoS One; 2013; 8(2):e51309. PubMed ID: 23408929
[TBL] [Abstract][Full Text] [Related]
10. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
[TBL] [Abstract][Full Text] [Related]
11. Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358.
Song SG; Yu HY; Ma YW; Zhang F; Xu XY
Tumour Biol; 2016 Oct; 37(10):13705-13719. PubMed ID: 27476167
[TBL] [Abstract][Full Text] [Related]
12. Critical role of mitochondria-mediated apoptosis for JNJ-26481585-induced antitumor activity in rhabdomyosarcoma.
Heinicke U; Kupka J; Fichter I; Fulda S
Oncogene; 2016 Jul; 35(28):3729-41. PubMed ID: 26616861
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression.
Yang Z; Yang X; Xu S; Jin P; Li X; Wei X; Liu D; Huang K; Long S; Wang Y; Sun C; Chen G; Hu J; Meng L; Ma D; Gao Q
Mol Cancer; 2017 Oct; 16(1):163. PubMed ID: 29041931
[TBL] [Abstract][Full Text] [Related]
14. Pro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2.
Merino D; Best SA; Asselin-Labat ML; Vaillant F; Pal B; Dickins RA; Anderson RL; Strasser A; Bouillet P; Lindeman GJ; Visvader JE
Oncogene; 2015 Jul; 34(30):3926-34. PubMed ID: 25263453
[TBL] [Abstract][Full Text] [Related]
15. Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression.
Blanco-Gómez A; Hontecillas-Prieto L; Corchado-Cobos R; García-Sancha N; Salvador N; Castellanos-Martín A; Sáez-Freire MDM; Mendiburu-Eliçabe M; Alonso-López D; De Las Rivas J; Lorente M; García-Casas A; Del Carmen S; Abad-Hernández MDM; Cruz-Hernández JJ; Rodríguez-Sánchez CA; Claros-Ampuero J; García-Cenador B; García-Criado J; Orimo A; Gridley T; Pérez-Losada J; Castillo-Lluva S
Cancer Res; 2020 Dec; 80(23):5216-5230. PubMed ID: 33023950
[TBL] [Abstract][Full Text] [Related]
16. 'Snail factors in testicular germ cell tumours and their regulation by the BMP4 signalling pathway'.
Micati DJ; Radhakrishnan K; Young JC; Rajpert-De Meyts E; Hime GR; Abud HE; Loveland KL
Andrology; 2020 Sep; 8(5):1456-1470. PubMed ID: 32441446
[TBL] [Abstract][Full Text] [Related]
17. PLAGL2 promotes the proliferation and migration of gastric cancer cells via USP37-mediated deubiquitination of Snail1.
Wu L; Zhao N; Zhou Z; Chen J; Han S; Zhang X; Bao H; Yuan W; Shu X
Theranostics; 2021; 11(2):700-714. PubMed ID: 33391500
[No Abstract] [Full Text] [Related]
18. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
19. SNAI2 as a novel radioprotector of normal tissue by gene transfer using a lentiviral bicistronic SIN vector.
Maier P; Herskind C; Barzan D; Zeller WJ; Wenz F
Radiat Res; 2010 May; 173(5):612-9. PubMed ID: 20426660
[TBL] [Abstract][Full Text] [Related]
20. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
